【结 构 式】 |
【分子编号】44355 【品名】4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)benzenesulfonyl chloride 【CA登记号】 |
【 分 子 式 】C17H19ClN4O4S 【 分 子 量 】410.88112 【元素组成】C 49.69% H 4.66% Cl 8.63% N 13.64% O 15.58% S 7.8% |
与该中间体有关的原料药合成路线共 2 条
合成路线1
该中间体在本合成路线中的序号:(V)Cyclization of 2-ethoxybenzamidine (I) with 2-butyramidopropionic acid (II) and ethoxalyl chloride (III) by means of DMAP in refluxing pyridine gives 2-(2-ethoxyphenyl)-5-methyl-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-4-one (IV), which is sulfonated with chlorosulfonic acid to provide the sulfonyl chloride (V). Finally, this compound is condensed with 1-ethylpiperazine (VI) in dichloromethane.
【1】 Niewohner, U.; Bischoff, E.; Es-Sayed, M.; Schenke, T.; Schmidt, G.; Lampe, T.; Haning, H.; Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors. Bioorg Med Chem Lett 2002, 12, 6, 865. |
【2】 Castaner, J.; Martin, L.; Rabasseda, X.; Sorbera, L.A.; Vardenafil. Drugs Fut 2001, 26, 2, 141. |
【3】 Perzborn, E.; Keldenich, J.; Schlemmer, K.-H.; Haning, H.; Serno, P.; Bischoff, E.; El-Sayed, M.; Niewöhner, U.; Nowakowski, M.; Schenke, T.; Dembowsky, K. (Bayer AG); 2-Phenyl substd. imidazotriazinones as phosphodiesterase inhibitors. DE 19750085; DE 19812462; EP 1049695; WO 9924433 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 44352 | 2-ethoxybenzenecarboximidamide | 53623-81-7 | C9H12N2O | 详情 | 详情 |
(II) | 44353 | N-butyrylalanine | C7H13NO3 | 详情 | 详情 | |
(III) | 11043 | Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride | 4755-77-5 | C4H5ClO3 | 详情 | 详情 |
(IV) | 44354 | 2-(2-ethoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one | C17H20N4O2 | 详情 | 详情 | |
(V) | 44355 | 4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)benzenesulfonyl chloride | C17H19ClN4O4S | 详情 | 详情 | |
(VI) | 14213 | N-Ethylpiperazine; 1-Ethylpiperazine | 5308-25-8 | C6H14N2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)
【1】 Pleiss U. 2003. Synthesis of [3H] vardenaffi,levitra, using a new labeling technique. J Label Comp Radiopharm, 46 (13): 1241~1247 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66919 | 4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)benzenesulfonic acid | C17H20N4O5S | 详情 | 详情 | |
(II) | 20674 | N-Acetyl piperazine; 1-(1-piperazinyl)-1-ethanone | 13889-98-0 | C6H12N2O | 详情 | 详情 |
(III) | 66920 | 2-(5-((4-acetylpiperazin-1-yl)sulfonyl)-2-ethoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one | C23H30N6O5S | 详情 | 详情 | |
(V) | 44355 | 4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)benzenesulfonyl chloride | C17H19ClN4O4S | 详情 | 详情 |
Extended Information